14 results · 18ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

CIRCA MATRIX12 M Esophageal Temperature Probe and Temperature Monitoring System

FDA 510(k)
FDA Class 2 ·General Hospital

Sonic

FDA UDI
Sonic Innovations, Inc.·05714464007172·SONIC RADIANT 60 MNR T R BL DEMO

HEALIX ADVANCE ORTHOCORD

FDA UDI
Medos International Sàrl·10886705021451·HEALIX ADVANCE PEEK 3 SUTURE ANCHOR w/ORTHOCORD...

BD Difco™ Neisseria Meningitidis Antiserum Group D

FDA UDI
BECTON, DICKINSON AND COMPANY·00382902223115·Vial N Meningitidis Antiserum Grp D

APEX PS Knee

FDA UDI
Omni Life Science, Inc.·00841690113577·PS-C Insert, Size 3 x 11mm

Ophthalmic Knife

FDA UDI
KATENA PRODUCTS, INC.·00841668113288·STAB KNIFE 22.5 DEGREE (BX/5)

GC-3000E DIGITAL COLPOSCOPE

FDA 510(k)
FDA Class 2 ·Obstetrics/Gynecology

RHINOSTREAM RHINOMANOMETER MODULE

FDA 510(k)
FDA Class 2 ·Anesthesiology

Ambassador Cervical Plate System

FDA UDI
Choice Spine, LP·00840996161220·AMBASSADOR,DRILL,2.3x11

CARPENTIER-EDWARDS PERIMOUNT RSR PERICARDIAL BIOPROSTHESIS

FDA Adverse Event
Injury ·EDWARDS LIFESCIENCES·Product code DYE·August 24, 2011

TOTAL ASR ACET IMP SIZE 54

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL LTD. 8010379·Product code KWA·November 4, 2014

GYNECARE TVT ABBREVO CONTINENCE SYSTEM

FDA Adverse Event
Injury ·ETHICON INC.·Product code OTN·July 12, 2013

ARGENT SURGICAL SYSTEMS***BIOPSY Punches*** Disposable manual instrument for skin biopsy.

FDA Enforcement
Class II ·Terminated·Clorox Healthcare Holdings, LLC (dba HealthLink)·July 10, 2013

Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014